Due to the ability of coronaviruses to bind to the angiotensin‐converting enzyme 2 (ACE2) receptors expressed in metabolic organs, it is plausible that early hyperglycaemia in COVID‐19+ patients could be related to the disease course itself.21 This evidence concerns the gene ACE2 and COVID-19.